Who may benefit from prophylactic cranial irradiation amongst stage III non-small cell lung cancer patients?

ALSAN ÇETİN İ., Akgun Z., ATASOY B. M., Yumuk P. F., ABACIOGLU M. U.

JOURNAL OF BUON, cilt.18, sa.2, ss.453-458, 2013 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 18 Sayı: 2
  • Basım Tarihi: 2013
  • Dergi Adı: JOURNAL OF BUON
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.453-458
  • Anahtar Kelimeler: brain metastasis, non-small cell lung cancer, prophylactic cranial irradiation, SOUTHWEST-ONCOLOGY-GROUP, MULTICENTER RANDOMIZED-TRIAL, TERM-FOLLOW-UP, BRAIN METASTASES, PHASE-II, PREOPERATIVE CHEMOTHERAPY, NEOADJUVANT CHEMOTHERAPY, MULTIMODALITY TREATMENT, FAILURE PATTERNS, GROUP RTOG
  • Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Hayır

Özet

Purpose: To identify a high risk group of non-small cell lung cancer (NSCLC) patients who may benefit from preventive strategies in order to reduce the rate of brain metastasis.